Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy

NYSE · Healthcare · Financials

Eli Lilly and Company (LLY) financial statements and cash flow.

Revenue, profitability, balance-sheet strength, and cash generation for LLY. Market data source · as of 2026-03-31.

Section freshness

Price Aug 4, 4:04 PM EDT · Statements Mar 30, 8:00 PM EDT

Financial read

LLY latest financial snapshot.

Start with the latest reported values below. Deeper quarterly and annual statement tables follow when supplied.

Revenue

$19.80B

+55.5% YoY

Net income

$7.40B

+11.4% QoQ

Net margin

37.36%

Balance sheet coverage

LLY balance sheet summary

Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.

20 quarterly · 4 annual rows · Market data source · as of 2026-03-31

Open balance sheet table

Latest period

Q1 FY2026

20 quarterly · 4 annual rows

Assets / liabilities

$116.58B

Liabilities —

Cash / debt

$5.28B

Net cash -$38.09B

Equity / working capital

$31.20B

Working capital $18.20B

Financial statements

LLY statement coverage.

Income statement, balance sheet, and cash-flow figures for LLY, with quarterly and annual history in the tables below.

Data last updated

Mar 30, 2026

Income periods

Balance-sheet periods

Cash-flow periods

Quarterly and annual LLY statements, sourced from Market data source · as of 2026-03-31.

Financial statement period

LLY statement history

Market data source · as of 2026-03-31 · Data last updated: Mar 30, 2026

ProfitabilityIncome statementRevenue, expenses, margins, and income quality20 quarterly periods Capital structureBalance sheetAssets, liabilities, debt, equity, and share count20 quarterly periods Cash generationCash flowOperating cash flow, CapEx, FCF, buybacks, and dividends20 quarterly periods

Income statement

Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.

8 / 20 Quarterly

Period	Revenue	Net income	Net margin	Revenue QoQ	Net income QoQ
Q1 FY2026	$19.80B	$7.40B	37.36%	+2.6%	+11.4%
Q4 FY2025	$19.29B	$6.64B	34.41%	+9.6%	+18.9%
Q3 FY2025	$17.60B	$5.58B	31.72%	+13.1%	-1.4%
Q2 FY2025	$15.56B	$5.66B	36.38%	+22.2%	+105.2%
Q1 FY2025	$12.73B	$2.76B	21.67%	-5.9%	-37.4%
Q4 FY2024	$13.53B	$4.41B	32.59%	+18.3%	+354.5%
Q3 FY2024	$11.44B	$970.30M	8.48%	+1.2%	-67.3%
Q2 FY2024	$11.30B	$2.97B	26.25%	+28.9%	+32.3%

Balance sheet

Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.

8 / 20 Quarterly

Period	Cash	Current assets	Current liabilities	Total assets	Total debt	Total equity	Debt QoQ
Q1 FY2026	$5.28B	$54.84B	$36.63B	$116.58B	$43.37B	$31.20B	+2.0%
Q4 FY2025	$7.27B	$55.63B	$35.23B	$112.48B	$42.50B	$26.54B	-0.0%
Q3 FY2025	$9.79B	$62.07B	$40.14B	$114.94B	$42.51B	$23.79B	+6.5%
Q2 FY2025	$3.38B	$49.85B	$39.02B	$100.92B	$39.90B	$18.27B	+3.6%
Q1 FY2025	$3.09B	$41.26B	$30.07B	$89.39B	$38.52B	$15.76B	+14.5%
Q4 FY2024	$3.27B	$32.74B	$28.38B	$78.72B	$33.64B	$14.27B	+8.1%
Q3 FY2024	$3.37B	$31.42B	$24.67B	$75.61B	$31.12B	$14.24B	+7.7%
Q2 FY2024	$3.22B	$30.20B	$27.12B	$71.87B	$28.89B	$13.56B	+10.2%

Cash flow

Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.

8 / 20 Quarterly

Period	Operating cash flow	Net income	Dividends paid	Buybacks
Q1 FY2026	$5.33B	$7.40B	$1.55B	$2.36B
Q4 FY2025	$3.22B	$6.64B	$1.35B	$1.51B
Q3 FY2025	$8.84B	$5.58B	$1.35B	$708.10M
Q2 FY2025	$3.09B	$5.66B	$1.35B	$692.20M
Q1 FY2025	$1.67B	$2.76B	$1.35B	$1.20B
Q4 FY2024	$2.47B	$4.41B	$1.17B	$2.05B
Q3 FY2024	$3.71B	$970.30M	$1.17B	$446.10M
Q2 FY2024	$1.47B	$2.97B	$1.17B	—

Valuation and returns

Enterprise value: $1.09T; TECHi computed

Return on equity: 81.02%; Market data source

Return on assets: 21.68%; Market data source

Debt / equity: 1.39; Current ratio 1.50

Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.

Annual revenue and income multiples

Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.

Annual revenue base: $65.18B; Annual statement 2025-12-31

Annual income base: $20.64B; Annual statement 2025-12-31

Market cap / annual revenue: 16.20; Live market value divided by annual revenue

Market cap / annual income: 51.16; Live market value divided by annual net income

Annual sales and income multiple

EV / annual revenue16.78

Market capitalization bridge

Market cap / annual revenue16.20

Market cap / annual income51.16

TTM valuation multiples

TTM revenue: $72.25B; Trailing twelve months

Market cap / TTM revenue: 14.61; Live market value divided by trailing twelve months revenue

EV / TTM revenue: 15.14; Enterprise value divided by trailing twelve months revenue

Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.

Profit multiples

Market cap / TTM net income41.77

Revenue, net income, and free cash flow

Revenue$19.80BNet income$7.40B

Q4 FY2024Q3 FY2025Q1 FY2026

Quarterly statement rows, shown on one common dollar scale so margin compression and cash conversion stand out quickly.

Efficiency

Revenue / employee: $1.44M; 50,000 employees

Net income / employee: $505,540; TTM net income divided by employees

Market cap / employee: $21.12M; Live value per employee

Growth vs cost pressure

Revenue growth YoY+55.5%

Debt growth YoY+12.6%

Quarterly margin heatmap

Gross margin

Q4 FY2024

—

Q1 FY2025

—

Q2 FY2025

—

Q3 FY2025

—

Q4 FY2025

—

Q1 FY2026

—

Operating margin

Q4 FY2024

—

Q1 FY2025

—

Q2 FY2025

—

Q3 FY2025

—

Q4 FY2025

—

Q1 FY2026

—

Net margin

Q4 FY2024

32.59%

Q1 FY2025

21.67%

Q2 FY2025

36.38%

Q3 FY2025

31.72%

Q4 FY2025

34.41%

Q1 FY2026

37.36%

Latest quarter expense mix

Cost of revenue$3.58B

SG&A$2.93B

Profit bridge

Pretax income$8.85B

Tax expense$1.45B

Other income statement lines

Income before tax$8.85B

Income tax expense$1.45B

Balance sheet · Q1 FY2026

Cash & equivalents: $5.28B

Total debt: $43.37B

Net cash: -$38.09B; Net debt position

Total equity: $31.20B

Balance sheet detail

Current assets: $54.84B

Current liabilities: $36.63B

Inventory: $14.53B

Receivables: $18.43B

Property, plant & equipment: $26.54B

Current debt: $4.00B

Long-term debt: $39.37B

Debt and liquidity

Debt / revenuei0.60

Debt / income1.72

Cash / debt0.12

Quick ratioi0.65

Cash + short-term investments + receivables / current liabilities

Cash generation

Operating cash flow: $5.33B

Capital returned: $3.90B; Buybacks + dividends paid

Cash-flow detail

Depreciation & amortization: $509.00M

Investing cash flow: -$3.92B

Financing cash flow: -$3.47B

Buybacks: $2.36B

Net buybacks: $2.36B; Repurchases less stock issuance

Dividends paid: $1.55B

Frequently asked

Common questions.

What financial data is available for LLY?

The LLY Financials page renders only the current income-statement, balance-sheet, cash-flow, or fund rows supplied for Eli Lilly and Company. Missing modules and empty line items are omitted.

How current are LLY's financial statements?

Each visible statement row keeps its reported period and provider attribution. The route redirects to the main quote when no usable financial or fund data remains.

What is Eli Lilly and Company's reported net margin?

Eli Lilly and Company's fresh reported margin field is 34.99%. The Financials page shows the supporting period data currently available for LLY.